Athletico Physical Therapy has opened a new location in Southlakeand is conveniently located in the Southlake Oaks…
Author: admin
FAIR Health to Launch Initiative Promoting Health Insurance Literacy to Hispanic and Latinx Communities
With a generous grant from The New York Community Trust (The Trust), FAIR Health, a national,…
Biovista Personalized Medicine and Diginova to deliver next generation AI-driven doctor/patient support in a deal that can generate over $5 Billion
Biovista Personalized Medicine and Diginova Health Solutions today announced their deal to deliver augmented intelligence (AI)-driven…
Advarra and Huron Join Forces to Optimize Clinical Research Site Performance
Advarra, the market leader in practice management technology for clinical research and regulatory review solutions today…
Nemours Children’s Health Officially Launches New Brand to Advance Children’s Health
Nemours Children’s Health has officially launched the new brand reflecting its bold strategy to redefine children’s…
Inova Health System to Present Key Digital Rounding Insights at Patient Experience Symposium in Boston
Patient engagement leader CipherHealth announced today that marquee customer Inova Health System will share key learnings to enhance patient experience…
The Physicians Foundation, Dr. Lorna Breen Heroes’ Foundation and #FirstRespondersFirst Come Together to Ignite National Action on Physician Suicide
In recognition of National Physician Suicide Awareness Day (September 17, 2021), The Physicians Foundation, Dr. Lorna…
Princeton Professor Launches Epicutis, a Professional Luxury Medical-Grade Skincare Line
Signum Biosciences, a biopharma company with 20 years of topical drug development and skincare ingredient expertise,…
Cardiovascular Therapeutics Market | Evolving Opportunities with Astellas Pharma Inc. and Eli Lilly and Co.
The global cardiovascular therapeutics market is expected to grow by $ 32.06 bn during 2021-2025, as per Technavio. This…
Fusion Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines,…